Macrophage membrane-camouflaged pH-sensitive nanoparticles for targeted therapy of oral squamous cell carcinoma
Journal of Nanobiotechnology · 12.04.2024 · 22 (1)
DOI: 10.1186/s12951-024-02433-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Nanobiotechnology, online erschienen am 12.04.2024. Verfasst von Lin Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endodontics, Stomatological Hospital of Chongqing Medical University, Chongqing, 404100, China. Hauptthemen laut MEDLINE: Carcinoma, Squamous Cell, Mouth Neoplasms, Head and Neck Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation Project of Chongqing Science and Technology Commission, National Natural Science Foundation of China, Program for Top talent Distinguished Progressor from Chongqing Medical University to DY.
Abstract (Originalsprache)
Background
Oral cancer is the most common malignant tumor of the head and neck, and 90% of cases are oral squamous cell carcinoma (OSCC). Chemotherapy is an important component of comprehensive treatment for OSCC. However, the clinical treatment effect of chemotherapy drugs, such as doxorubicin (DOX), is limited due to the lack of tumor targeting and rapid clearance by the immune system. Thus, based on the tumor-targeting and immune evasion abilities of macrophages, macrophage membrane-encapsulated poly(methyl vinyl ether alt maleic anhydride)-phenylboronic acid-doxorubicin nanoparticles (MM@PMVEMA-PBA-DOX NPs), briefly as MM@DOX NPs, were designed to target OSCC. The boronate ester bonds between PBA and DOX responded to the low pH value in the tumor microenvironment, selectively releasing the loaded DOX.
Results
The results showed that MM@DOX NPs exhibited uniform particle size and typical core-shell structure. As the pH decreased from 7.4 to 5.5, drug release increased from 14 to 21%. The in vitro targeting ability, immune evasion ability, and cytotoxicity of MM@DOX NPs were verified in HN6 and SCC15 cell lines. Compared to free DOX, flow cytometry and fluorescence images demonstrated higher uptake of MM@DOX NPs by tumor cells and lower uptake by macrophages. Cell toxicity and live/dead staining experiments showed that MM@DOX NPs exhibited stronger in vitro antitumor effects than free DOX. The targeting and therapeutic effects were further confirmed in vivo. Based on in vivo biodistribution of the nanoparticles, the accumulation of MM@DOX NPs at the tumor site was increased. The pharmacokinetic results demonstrated a longer half-life of 9.26 h for MM@DOX NPs compared to 1.94 h for free DOX. Moreover, MM@DOX NPs exhibited stronger tumor suppression effects in HN6 tumor-bearing mice and good biocompatibility.
Conclusions
Therefore, MM@DOX NPs is a safe and efficient therapeutic platform for OSCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endodontics, Stomatological Hospital of Chongqing Medical University, Chongqing, 404100, China.
- Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, Stomatological Hospital of Chongqing Medical University, Chongqing, 404100, China.
- Chongqing Municipal Key Laboratory of Oral Biomedical Engineering of Higher Education, Chongqing, 404100, China.
- Chongqing Key Laboratory of Oral Diseases and Biomedical Sciences, 426 Songshi North Road, Yubei District, Chongqing, 401147, China.
- Key Laboratory for Biorheological Science and Technology of Ministry of Education, State and Local Joint Engineering Laboratory for Vascular Implants, Bioengineering College of Chongqing University, Chongqing, 400044, C…
- Department of Endodontics, Stomatological Hospital of Chongqing Medical University, Chongqing, 404100, China. yangdeqin@hospital.cqmu.edu.cn.
Förderung
- Natural Science Foundation Project of Chongqing Science and Technology Commission
- National Natural Science Foundation of China
- Program for Top talent Distinguished Progressor from Chongqing Medical University to DY
Zitieren
APA
Yang, L., Li, H., Luo, A., Zhang, Y., Chen, H., Zhu, L., & Yang, D. (2024). Macrophage membrane-camouflaged pH-sensitive nanoparticles for targeted therapy of oral squamous cell carcinoma. Journal of Nanobiotechnology, 22(1). https://doi.org/10.1186/s12951-024-02433-4
Vancouver
Yang L, Li H, Luo A, Zhang Y, Chen H, Zhu L, et al. Macrophage membrane-camouflaged pH-sensitive nanoparticles for targeted therapy of oral squamous cell carcinoma. Journal of Nanobiotechnology. 2024;22(1). doi:10.1186/s12951-024-02433-4
BibTeX
@article{Yang2024,
author = {Yang, Lin and Li, Hongjiao and Luo, Aihua and Zhang, Yao and Chen, Hong and Zhu, Li and Yang, Deqin},
title = {Macrophage membrane-camouflaged pH-sensitive nanoparticles for targeted therapy of oral squamous cell carcinoma},
journal = {Journal of Nanobiotechnology},
year = {2024},
volume = {22},
number = {1},
doi = {10.1186/s12951-024-02433-4}
}
EUVIMED